Extendicare Inc. (TSE:EXE - Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$9.43 and traded as high as C$11.03. Extendicare shares last traded at C$10.73, with a volume of 153,937 shares trading hands.
Analyst Ratings Changes
A number of research analysts recently weighed in on the stock. TD Securities lifted their target price on shares of Extendicare from C$9.50 to C$10.50 and gave the company a "hold" rating in a research note on Thursday, November 14th. Royal Bank of Canada lifted their target price on shares of Extendicare from C$9.50 to C$11.00 and gave the company a "sector perform" rating in a research note on Thursday, November 28th. Finally, BMO Capital Markets set a C$11.00 price target on shares of Extendicare and gave the stock a "market perform" rating in a research note on Thursday, January 30th.
Read Our Latest Stock Analysis on Extendicare
Extendicare Stock Performance
The firm has a market cap of C$928.15 million, a PE ratio of 14.18 and a beta of 1.26. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The firm's 50 day simple moving average is C$10.43 and its 200 day simple moving average is C$9.48.
Extendicare Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 17th will be paid a $0.04 dividend. This represents a $0.48 annualized dividend and a yield of 4.32%. The ex-dividend date is Friday, February 28th. Extendicare's payout ratio is currently 61.20%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
